Home Page News Statistics API Review Formulation Monthly Im&Ex report All Information
     
Keyword:
 E-mail:xuezhe@healthoo.com
 Tel.:86-10-68032463
  Our services:
 China Im\Ex data service
 Service fees of Chinese Vision
 Our service items
Online information introduction
Monthly information
Conference on ...
Information Release...
Internationalization&nbs...
Welcome to Pro...
Healthoo.com Carbap...
APIs Innovation&nbs...
China Import Export Statistics Report In...
API Export Price by ...
Tylosin Bulk Drug Export&...
China Monthly Export Stat...
China Monthly Export Stat...
China Monthly Export Stat...
Your position:www.healthoo.com >> EN >> Industry
Merger to grow China's private health care2014-02-21
Fuyang's Maltose and Trehalose into polit production2014-02-21
Citric acid export in Laiwu increased in 20132014-02-20
China's pharmaceutical foreign trade increased in 20132014-02-11
Drug prices down through unified bidding in Shenzhen2014-02-10
China to unify rural, urban pension systems2014-02-08
Yihai Cereal started to build vitamin E project2014-02-08
Beijing competes to spearhead national medical reforms2014-02-07
Sagent launches National Research Centre in Chengdu2014-02-07
Alibaba to fund pharmaceutical business platform2014-01-27
Analysts optimistic about China's economic growth2014-01-23
Actavis to exit China's generic drug market2014-01-22
Meihua's Sodium glutamate export increased in 20132014-01-21
NCPC's revenue reaches 20 Bln Yuan in 20132014-01-20
New-Dankong promotes sale of Atorvastatin Calcium tablets2014-01-15
Wannianchang Pharma to build Rosuvastatin and Atorvastatin project2014-01-15
TCM companies eyeing global market2014-01-14
Chongqing further develops pharmaceutical industry clusters2014-01-13
3 expensive anticancer drugs into medicare in Nanjing2014-01-13
Export license administration continued for Penicillin G, Vitamin C in 20142014-01-10
60.3% sterile medicine producers passed new GMP2014-01-08
Shenhao's medicine grade Inositol into production2014-01-07
China rules out vaccine death link2014-01-06
China suspends Pfizer import of Fluconazole injection2014-01-02
Shenzhen Hepalink to acquire US APIs enterprise SPL2013-12-27
Yabao's solid formulation workshop passed US cGMP2013-12-24
China bans Shenzhen hepatitis B vaccine2013-12-23
GSK revamps sales reps' compensation2013-12-20
Antitrust office beefs up price fixing squad2013-12-17
US judged China's Coenzyme Q10 not infringing the patent2013-12-16
More US FDA supervisors in China2013-12-13
China bans imports of ROK medical product2013-12-10
1471个 页次:10/4632个/页 首页 上一页 下一页 尾页 转到:
Our Advantages of Reports
①All reports written by ourselves
②All data having original sources
③Information is the latest
④Continuous historical data
⑤Objective analysis and remark
Purchase Flow of Reports
①Confirm purchase (If necessary sign the contract)
②Transfer payment to company's bank account
③After accepting payment we email the report to clients (PDF format)
④Send the invoice
Bank account
①Beneficiary's Name:Beijing orientbit technology ltd
②Beneficiary's Account No.:110060239018002127366
③Name of bank:Bank of Communications Beijing Branch,Fuwai Sub-Branch
④Address of bank:NO7,FUWAISTREET,XICHENG DISTRICT,BEIJING,CHINA SWIFT CODE:COMMCNSHBJG
Address: Suite 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
Tel:+86-10-68032463